Interleukin-1β and tumor necrosis factor-α inhibit the release of [3H]-Haradrenaline from isolated human atrial appendages

Naunyn-Schmiedeberg's Archives of Pharmacology

Volumn 355, Issue 3, 1997, Pages 384-389

  Abadie, Claire ^a   Foucart, Sylvain ^a   Pagé, Pierre ^a   Nadeau, Réginald ^a  

^a HÔPITAL DU SACRÉ COEUR DE MONTRÉAL   (Canada)

Author keywords

Cytokines; Human atrial appendage; Interleukin 1 ; Noradrenaline release; Presynaptic modulation; Tumor necrosis factor

Indexed keywords

RECOMBINANT INTERLEUKIN 1BETA; RECOMBINANT TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CONTROLLED STUDY; ELECTROSTIMULATION; HEART ATRIUM; HUMAN; HUMAN TISSUE; IN VITRO STUDY; NORADRENALIN RELEASE;

EID: 0030939797     PISSN: 00281298     EISSN: None     Source Type: Journal    
DOI: 10.1007/PL00004958     Document Type: Article

References (44)

1. Abadie C, Foucart S, Pagé P, Nadeau R (1996) Modulation of noradrenaline release from human atrial appendages. J Auton Nerv Syst 61:269-276
2. Ader R, Felten D, Cohen N (1990) Interactions between the brain and the immune system. Annu Rev Pharmacol Toxicol 30:561-602
3. Bataillard A, Sassard J (1994) Cardiovascular effects of human recombinant interleukin-1β in conscious rats. Am J Physiol 266:R1148-R1153
4. Bognar IT, Albrecht SA, Farasaty M, Schmitt E, Seidel G, Fuder H (1994) Effects of recombinant interleukins on stimulation-evoked noradrenaline overflow from the rat perfused. Naunyn-Schmiedeberg's Arch Pharmacol 349:497-502
5. Bognar IT, Albrecht SA, Farasaty M, Fuder H (1995) Inhibition by interleukin-1β of noradrenaline release in rat spleen: involvement of lymphocytes, NO and opioid receptors. Naunyn-Schmiedeberg's Arch Pharmacol 351:433-438
6. Calandra T, Baumgartner JD, Grau MM, Wu MM, Lambert PH, Schellekens J, Verhoef J, Glausser MP (1990) Prognostic values of tumor necrosis factor/cachectin, interleukin-1, interferon-alpha, and interferon-gamma in the serum of patients with septic shock. J Infect Dis 161:982-987
7. Chang JY, Martin DP, Johnson EM (1990) Interferon suppresses sympathetic neuronal cell death caused by nerve growth factor deprivation. J Neurochem 55:436-445
8. Dinarello CA (1991) The proinflammatory cytokines interleukin-1 and tumor necrosis factor and treatment of the septic shock syndrome. J Infect Dis 163:1177-1184
9. Durum SK, Quinn DG, Muegge K (1991) New cytokines and receptors make their debut in San Antonio. Immunol Today 12:54-57
10. Eisenberg SP, Evans SP, Arend WP, Verderber E, Brewer MT, Hannum CH, Thompson RC (1990) Primary structure and functional expression from complementary DNA of a human interleukin-1 receptor antagonist. Nature (Lond) 343:341-346
11. Elenkov IJ, Kovacs K, Duda E, Stark E, Vizi ES (1992) Presynaptic inhibitory effect of TNF-α on the release of noradrenaline in isolated median eminence. J Neuroimmunol 41:117-120
12. 3H]-noradrenaline from mice isolated atria. Naunyn-Schmiedeberg's Arch Pharmacol 354:1-6
13. Hannum CH, Wilcox CJ, Arend WP, Joslin FG, Dripps DJ, Heimjal PL, Armes LG, Sommer A, Eisenberg SP, Thompson RC (1990) Interleukin-1 receptor antagonist activity of a human interleukin-1 inhibitor. Nature (Lond) 343:336-340
14. Heard SO, Perkins MW, Fink MP (1992) Tumor necrosis factor-α causes myocardial depression in guinea pigs. Crit Care Med 20:523-527
15. Hosenpud JD, Campbell SM, Mendelson DJ (1989) Interleukin-1-induced myocardial depression in an isolated beating heart preparation. J Heart Lung Transplant 8:460-464
16. Hurst S, Collins SM (1993) Interleukin-1β modulation of norepinephrine release from rat myenteric nerves. Am J Physiol 264:G30-G35
17. Hurst S, Collins SM (1994) Mechanism underlying tumor necrosis factor-α suppression of norepinephrine release from rat myenteric plexus. Am J Physiol 266:G1123-G1129
18. Ignatowski TA, Spengler RN (1994) Tumor necrosis factor-α sensibility is modified alter antidepressant drug administration. Brain Res 665:293-299
19. 3-receptors in human heart. Circ Res 77:206-210
20. Johnston H, Majewski H, Musgrave IF (1987) Involvement of cyclic nucleotides in prejunctional modulation of noradrenaline release in mouse atria. Br J Pharmacol 91:773-781
21. Jonakait GM (1993) Neural-immune interactions in sympathetic ganglia. Trends Neurosci 16:419-123
22. Kapadia S, Lee J, Torre-amione G, Birdsall HH, Ma TS, Mann DL (1995) Tumor necrosis factor-α gene and protein expression in adult feline myocardium after endotoxin administration. J Clin Invest 96:1042-1052
23. Langer SZ (1981) Presynaptic regulation of the release of catecholamines. Pharmacol Rev 32:337-362
24. Lennard AC (1995) Interleukin-1 receptor antagonist. Crit Rev Immunol 15:77-105
25. Luger A, Graf H, Schwarz HP, Stummvoll HK, Luger TA (1986) Decreased serum interleukin-1 activity and monocyte interleukin-1 production in patients with fatal sepsis. Crit Care Med 14:458-461
26. Mathison JC, Wolfson E, Ulevitch RJ (1988) Participation of tumor necrosis factor in the mediation of gram negative bacterial lipopolysaccharide-induced injury in rabbits. J Clin Invest 81:1925-1937
27. MohanKumar PS, Quadri SK (1993) Systemic administration of interleukin-1 stimulates norepinephrine release in the paraventricular nucleus. Life Sci 52:1961-1967
28. 1Dα receptors in human atrium. Naunyn-Schmiedeberg's Arch Pharmacol 353:272-280
29. Morimoto K, Morimoto A, Nakamori T, Tan N, Minagawa T, Murakami N (1992) Cardiovascular responses induced in free-moving rats by immune cytokines. J Physiol 448:307-320
30. Niijima A, Hori T, Aou S, Oomura Y (1991) The effects of interleukin-1β on the activity of adrenal, splenic and renal sympathetic nerves in the rat. J Auton Nerv Syst 36:183-192
31. Okusawa S, Gelfand JA, Ikejima T, Connolly RJ, Dinarello CA (1988) Interleukin-1 induces a shock-like state in rabbits. Synergism with tumor necrosis factor and the effects of cyclooxygenase inhibition. J Clin Invest 81:1162-1172
32. Petitclerc E, Abel S, deBlois D, Poubelle PE, Marceau F (1992) Effects of interleukin-1 receptor antagonist on three types of responses to interleukin-1 in rabbit isolated blood vessels. J Cardiovasc Pharmacol 19:821-829
33. 2-adrenergic receptor and angiotensin II receptor modulation of sympathetic neurotransmission in human atria. Circ Res 74:434-440
34. Rump LC, Bohmann C, Schaible U, Schultze-Seemann W, Schollmeyer PJ (1995) Dopaminergic and α-adrenergic control of neurotransmission in human right atrium. J Cardiovasc Pharmacol 26:462-470
35. Schulz R, Panas DL, Catena R, Moncada S, Olley PM, Lopaschuk GD (1995) The role of nitric oxide in cardiac depression induced by interleukin-1β and tumour necrosis factor-α. Br J Pharmacol 114:27-34
36. Shintani F, Kanba S, Nakaki T, Nibuya M, Kinoshita N, Suzuki E, Yagi G, Kato R, Asai M (1993) Interleukin-1β augments release of norepinephrine, dopamine, and serotonin in the rat anterior hypothalamus. J Neurosci 13:3574-3581
37. Starke K (1977) Regulation of noradrenaline release by presynaptic receptor systems. Rev Physiol Biochem Pharmacol 77:1-124
38. Takahashi H, Nishimura M, Sakamoto M, Ikegali I, Nakanishi T, Yoshimura M (1992) Effects of interleukin-1β on blood pressure, sympathetic nerve activity, and pituitary endocrine functions in anesthetized rats. Am J Hypertens 5:224-229
39. Terao A, Oikawa M, Saito M (1993) Cytokine-induced change in hypothalamic norepinephrine turnover: involvement of corticotropin-releasing hormone and prostaglandins. Brain Res 622:257-261
40. 2 in interleukin-1-induced activation of norepinephrine turnover in the brain and peripheral organs of rats. J Neurochem 65:2742-2747
41. Vriend CY, Zuo L, Dyck DG, Nance DN, Greenberg AH (1993) Central administration of interleukin-1β increases norepinephrine turnover in the spleen. Brain Res Bull 31:39-42
42. Weinberg JR, Wright DJM, Guz A (1988) Interleukin-1 and tumor necrosis factor cause hypotension in the conscious rabbit. Clinical Sci 75:251-255
43. Westfall TC (1977) Local regulation of adrenergic neurotransmission. Physiol Rev 57:659-728
44. Yanagihara N, Minami K, Shirakawa F, Uezono Y, Kobayashi H, Eto S, Izumi F (1994) Stimulation effect of IL-1β on catecholamine secretion from cultured bovine adrenal medullary cells. Biochem Biophys Res Commun 198:81-87